K M C Speciality Hospitals (India) Limited (KMCSHIL) fundamentals
K M C Speciality Hospitals (India) Limited is a listed company, part of the Healthcare Services sector, listed on the NSE as KMCSHIL (ISIN INE879K01018). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What K M C Speciality Hospitals (India) Limited does
KMC Speciality Hospitals (India) Limited is an India-based company, which is engaged in the business of rendering medical and healthcare services. The Company operates through Medical and Healthcare Services segment. It provides various services, such as anesthesiology, cardiology, critical care, dermatology, dental maxillofacial, ophthalmology, endocrinology, general surgery, ENT, head and neck surgery, laboratory services, obstetrics and gynecology, IVF and infertility, psychiatry, pulmonology, rheumatology, lung center, general medicine, diabetology, orthopedics, oncology, spine surgery, neurology, liver disease, gastroenterology, geriatrics, nephrology and urology science, vascular surgery, pediatrics and neonatology, infectious diseases, plastic surgery, breast clinic, maa kauvery-comprehensive mother and childcare. It provides various services through its centers, such as cardiac science, neurology, general medicine, diabetology, spine surgery, orthopedics, geriatrics, and more.
Valuation and market data
| Last close | ₹138.50 |
|---|---|
| Market capitalisation | ₹2,266 crore |
| Enterprise value | ₹2,340 crore |
| P/E (TTM) | 0.00 |
| Price to book | 13.79 |
| Price to sales (TTM) | 6.72 |
| Book value per share | ₹10.05 |
| Dividend yield | 0.00% |
| Sector | Healthcare Services |
| Industry | — |
| Listed since | Mon Aug 17 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹311 crore | ₹63 crore | ₹47 crore | 0.00 |
| Mar 2025 | ₹235 crore | ₹32 crore | ₹21 crore | 1.31 |
| Mar 2024 | ₹181 crore | ₹41 crore | ₹30 crore | 1.86 |
| Mar 2023 | ₹159 crore | ₹36 crore | ₹27 crore | 1.64 |
| Mar 2022 | ₹138 crore | ₹32 crore | ₹24 crore | 1.45 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 75.0% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 25.0% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.